Picture of Foxo Technologies logo

FOXO Foxo Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-16.84%
3m-2.55%
6m-74.1%
1yr-94.97%
Volume Change (%)
10d/3m-75.08%
Price vs... (%)
52w High-94.64%
50d MA-11.91%
200d MA-61.54%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equity-2538.8%
Operating Margin-9051.43%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Foxo Technologies EPS forecast chart

Profile Summary

FOXO Technologies Inc. is a biotechnology company. The Company is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The Company operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    April 27th, 2020
    Public Since
    December 11th, 2020
    No. of Shareholders
    75
    No. of Employees
    24
    Sector
    Software & IT Services
    Industry
    Technology
    Exchange
    us flag iconNYSE MKT
    Shares in Issue
    8,946,032

    FOXO Share Price Performance

    Upcoming Events for FOXO

    Q4 2023 Foxo Technologies Inc Earnings Release

    Q1 2024 Foxo Technologies Inc Earnings Release

    Foxo Technologies Inc Annual Shareholders Meeting

    Q2 2024 Foxo Technologies Inc Earnings Release

    Similar to FOXO

    Picture of Arena group logo

    Arena group

    us flag iconNYSE MKT

    Picture of Castellum logo

    Castellum

    us flag iconNYSE MKT

    Picture of Inuvo logo

    Inuvo

    us flag iconNYSE MKT

    FAQ